Seonggyu Byeon

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.

|Aug 19, 2026
Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data.

|Dec 23, 2023
Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer.

Seonggyu Byeon, Jaeyun Jung, Seung Tae Kim

|Sep 20, 2021
Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell model.

Song-Yi Lee, Seonggyu Byeon, Jihoon Ko

|Sep 28, 2020
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study.

Seonggyu Byeon, Hyera Kim, Jinchul Kim

|Feb 07, 2020
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence.

Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung

Pageof 2

Frequent Collaborators

2 joint publications

Suein Choi

2 joint publications

Sung-Soo Park

1 joint publications

Myung-Ju Ahn

1 joint publications

Hyera Kim